Table 2 Participants’ characteristics and values for selected variables before the first allocation
Olmesartan | Enalapril | P-value | |
|---|---|---|---|
(n = 17) | (n = 13) | ||
Age, years | 60.2 (12.9) | 59.9 (11.6) | NS |
Female, n (%) | 8 (47.1) | 2 (15.4) | <0.0001 |
BMI, kg/m2 | 27.7 (6.2) | 27.41 (4.1) | NS |
Systolic blood pressure, mm Hg | 134.8 (4.2) | 140.1 (4.2) | NS |
Diastolic blood pressure, mm Hg | 78.7 (1.7) | 76.2 (1.8) | NS |
Dyslipidaemia, n (%) | 6 (35.3) | 5 (38.5) | NS |
Serum creatinine, mg/dl | 1.65 (0.07) | 1.60 (0.06) | NS |
Glomerular filtration rate, ml/min/1.73 m2 | 42.24 (2.0) | 46.2 (1.9) | NS |
Plasma renin activity, ng/ml/h | 1.13 (1.12) | 1.30 (1.46) | NS |
Plasma aldosterone, ng/dl | 30.6 (4.0) | 27.1 (5.5) | NS |
Diabetic patients, n (%) | 1 (5,8) | 2(15) | NS |